Education And Debate Cochrane at crossroads over drug company sponsorship BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7420.924 (Published 16 October 2003) Cite this as: BMJ 2003;327:924 Article Related content Metrics Responses Peer review Related articles News Roundup [abridged Versions Appear In The Paper Journal] Cochrane proposes further limits on commercial funding Published: 12 February 2004; BMJ 328 doi:10.1136/bmj.328.7436.366 Feature Has Cochrane lost its way? Published: 03 January 2019; BMJ 364 doi:10.1136/bmj.k5302 See more Children call for root and branch reform of air pollution BMJ June 28, 2022, 377 o1576; DOI: https://doi.org/10.1136/bmj.o1576 NHS loses 13.5 million hours of doctors’ time a year owing to IT problems, says BMA BMJ June 28, 2022, 377 o1596; DOI: https://doi.org/10.1136/bmj.o1596 BMA must challenge new GP contract with “industrial action if necessary,” say doctors BMJ June 28, 2022, 377 o1599; DOI: https://doi.org/10.1136/bmj.o1599 GMC must focus on “significant breaches” only, say doctors BMJ June 28, 2022, 377 o1594; DOI: https://doi.org/10.1136/bmj.o1594 Partha Kar: Understanding how others relate to you BMJ June 28, 2022, 377 o1548; DOI: https://doi.org/10.1136/bmj.o1548 Cited by... Has Cochrane lost its way?Fulltext PDF New Cochrane policy tightens limits on industry fundingFulltext PDF
